US Patent Issued to REGENERON PHARMACEUTICALS on May 6 for "Metabolically optimized cell culture" (New York, Connecticut, Georgia Inventors)

ALEXANDRIA, Va., June 10 -- United States Patent no. 12,291,563, issued on May 6, was assigned to REGENERON PHARMACEUTICALS INC. (Tarrytown, N.Y.).

"Metabolically optimized cell culture" was invented by Shawn Lawrence (Valley Cottage, N.Y.), Michelle Lafond (Pleasantville, N.Y.), Ann Kim (White Plains, N.Y.), Amy S. Johnson (Briarcliff Manor, N.Y.), Brandon Veres (White Plains, N.Y.), Mark Czeterko (Stamford, Conn.) and Kristen Whalen (Brookhaven, Ga.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Improved methods for large scale production of proteins and/or polypeptides in cell culture is provided. In accordance with the present invention, the method provides for culturing cells that have metabolically shi...